Minireviews Open Access
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Sep 18, 2024; 12(3): 94519
Published online Sep 18, 2024. doi: 10.13105/wjma.v12.i3.94519
Vascular complications of liver abscess: A literature review
Rahul Arya, Ramesh Kumar, Department of Gastroenterology, All India Institute of Medical Sciences, Patna 801507, Bihar, India
Rajeev N Priyadarshi, Ruchika Narayan, Department of Radiodiagnosis, All India Institute of Medical Sciences, Patna 801507, Bihar, India
Utpal Anand, Department of Surgical Gastroenterology, All India Institute of Medical Sciences, Patna 801507, India
ORCID number: Rahul Arya (0000-0003-3714-0990); Ramesh Kumar (0000-0001-5136-4865); Rajeev N Priyadarshi (0000-0003-2890-8910); Ruchika Narayan (0000-0001-5569-7499); Utpal Anand (0000-0003-0653-4129).
Author contributions: Arya R, Kumar R, and Priyadarshi RN contributed to the concept and design of the manuscript, data collection, and wrote manuscript; Narayan R and Anand U contributed to the data collection, critical input, and manuscript writing; All authors have made a significant contribution and approved the final manuscript.
Conflict-of-interest statement: All authors have no conflict-of-interest to declare.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ramesh Kumar, MBBS, MD, Additional Professor, Department of Gastroenterology, All India Institute of Medical Sciences, Phulwari Sharif, Patna 801507, Bihar, India. docrameshkr@gmail.com
Received: March 19, 2024
Revised: August 23, 2024
Accepted: August 30, 2024
Published online: September 18, 2024
Processing time: 177 Days and 15.8 Hours

Abstract

Extensive vascular network and proximity to the gastrointestinal tract make the liver susceptible to abscess formation. While pyogenic liver abscesses account for the majority of liver abscesses in the Western world, amebic liver abscesses are more prevalent in tropical and developing nations. Most liver abscesses heal without complications. However, various vascular complications can occur in these patients, including compression of the inferior vena cava, thrombosis of the portal vein and/or hepatic veins, hepatic artery pseudoaneurysm, direct rupture into major vessels or the pericardium, and biliovascular fistula. These complications can present significant clinical challenges due to the potential for haemorrhage, ischemia, and systemic embolism, thereby increasing the risk of morbidity and mortality. Mechanical compression, flow stasis, inflammation, endothelial injury, and direct invasion are some of the proposed mechanisms that can cause vascular complications in the setting of a liver abscess. For the diagnosis, thorough assessment, and therapeutic planning of vascular complications, more sophisticated imaging techniques such as multidetector computed tomography angiography or magnetic resonance angiography may be necessary. Although most vascular complications resolve with abscess treatment alone, additional interventions may be required based on the nature, severity, and course of the complications. This article aims to provide a systematic update on the spectrum of vascular complications of liver abscesses, offering insights into their pathogenesis, diagnosis, and management strategies.

Key Words: Liver abscess; Pylephlebitis; Venous thrombosis; Pseudoaneurysm; Portal cavernoma; Inferior vena cava obstruction

Core Tip: Liver abscess is a focal infection of hepatic parenchyma caused by various bacteria and the protozoa Entamoeba histolytica. It poses a considerable risk of vascular complications, including venous thrombosis, arterial pseudoaneurysms, thromboembolism, and biliary communication, as these complications can cause ischemia and hemorrhages, presenting significant challenges to clinicians. This review summarizes the existing literature on these lesser-known complications, providing insights into their magnitude, mechanistic pathogenesis, diagnosis, and management strategies.



INTRODUCTION

A liver abscess (LA) is a significant infectious complication of the liver parenchyma that requires accurate diagnosis and targeted treatment. Most LAs are classified as amebic liver abscesses (ALA), caused by the anaerobic protozoan Entamoeba histolytica, or pyogenic liver abscesses (PLA), caused by various bacteria. Rarely, an LA can be of fungal or tubercular origin. ALA is usually a non-suppurative liver infection with thick brown, odorless, and sterile acellular debris[1]. In contrast, PLA is a pus-filled, suppurative liver infection that is usually culture-positive. PLA is mostly polymicrobial with certain organisms, including Klebsiella, Escherichia coli, Anaerobes, Streptococcus, and Staphylococcus being more frequently noted[2]. There has been a perceptible global trend in the incidence of LA[3]. Certain conditions, such as diabetes mellitus, male gender, advanced age, and impaired immune systems, render individuals more susceptible to LA[2]. The incidence and forms of LA differ geographically, with higher ALA prevalence in tropical regions and developing countries such as the Indian subcontinent, Africa, Central and South America, and Mexico[4]. ALA constitutes over 80% of all LA cases in India[5]. The predominant form of LA in the Western world is PLA, with an incidence rate of 2.3 per 100000 population in North America[6]. Males over 60 have a higher prevalence of PLA.

The liver is vulnerable to both ALA and PLA due to its complex vascular network and close relationship with the gastrointestinal (GI) tract. The dual blood supply of the liver, comprising the portal vein (PV) and hepatic artery (HA), is unique among visceral organs[7]. The liver's proximity to many vessels increases its vulnerability to the hematogenous dissemination of infections and potential vascular complications[8]. These complications arising from LA encompass a wide spectrum, including vascular thrombosis, thromboembolism, rupture into large vessels, and pseudoaneurysm, underscoring the intricacy of the condition. Pulmonary thromboembolism and trans-diaphragmatic rupture into the heart, resulting in cardiac tamponade, are among LA’s potentially fatal complications[9-12]. Patients with PLA and ALA have both been reported to have vascular complications. In a large study from India, vascular complications were reported in 93 of 1630 LA patients (5.7%)[13]. However, up to 69% of ALA patients had venous thrombosis, in a recent study specifically designed to identify vascular complications using a multidetector computed tomography (CT) scan[14]. Several proposed mechanisms can lead to vascular complications in the context of LAs, including vascular compression, flow stasis, inflammation, endothelial damage, and direct invasion[4,15-17]. Further, chronic inflammation can weaken the HA wall, making it vulnerable to the development of hepatic artery pseudoaneurysm (HAPA) and its eventual rupture[18,19]. This article aims to provide an update on the spectrum of vascular complications of LA, including their pathophysiology, diagnostic approach, and therapeutic considerations. A systematic literature search up to February 2024 was performed using PubMed and Google Scholar database for the purpose of this article.

VASCULAR ANATOMY OF THE LIVER IN RELEVANCE TO LA

The development of LA is significantly influenced by the liver’s vascular architecture. The liver is divided into eight segments, each with a separate vascular supply. Based on the blood supply to particular hepatic segments, LA may be the site of localization. Comprehending this segmental blood flow facilitates the understanding of the mechanisms by which infections enter the liver parenchyma. The amebic trophozoites colonize the cecum, invade the mucosa, and enter the liver through the portal circulation to cause ALA[4]. The right lobe of the liver is more frequently affected by ALA because the superior mesenteric vein, which drains the area of the intestine where trophozoites invade, is the main conduit for portal blood flow to the liver. In the case of PLA, where bacterial invasion can occur through the venous, arterial, or biliary systems, such lobar preference is not shown. Generally, biliary tract infections or ascending cholangitis cause right lobe PLA, whereas diverticulitis or colonic cancer can cause PLA in the left lobe[2]. The inferior vena cava (IVC) is more susceptible to compression and thrombosis from the LA of the caudate lobe due to its proximity[20]. The liver is an important defense against microbial invasion. Therefore, bacteria may evade the hepatic filtration mechanisms in situations of portal vein thrombosis (PVT), raising the risk of infections, including PLA[2].

MECHANISMS OF VASCULAR INVOLVEMENT IN LA

Several factors contribute to vascular involvement in LA, including the followings:

Hemodynamic changes due to compression

An expanding LA exerts pressure on nearby vessels, compromising their integrity and functionality, leading to alterations in blood flow[16,21]. The resultant pockets of stagnant blood can foster the development of thrombi. These thrombi can further impair blood flow and affect the cellular function and viability of the hepatic cells around the LA by preventing the delivery of oxygen and nutrients[22].

Inflammation and endothelial damage

Within the liver parenchyma, microbial invasion sets off a series of inflammatory reactions. The inflammatory mediators generated in response impact the surrounding vasculature, besides the abscess site. Vascular endothelial cells are essential for maintaining structural integrity. The inflammatory processes sparked by microbial invasion cause endothelial injury in nearby blood vessels, jeopardizing the structural integrity of vessels[23,24]. A pro-thrombotic surface created by damaged endothelial cells encourages platelet adhesion and activation. The coagulation cascade that leads to thrombus formation is initiated when platelets attach to the exposed subendothelial matrix[25]. The thrombus can impede blood flow in the involved vessels, worsening the compromised blood flow. In a recent study, 69% of ALA patients had venous thrombosis, and 53% showed a zone of perilesional ischemia[14]. Despite extensive thrombosis of the IVC and HV, underlying thrombophilia states were found negative in a study, highlighting the thrombogenic potential of ALA[26]. Besides thrombotic complications, inflammatory damage to nearby arteries may cause the accumulation of blood between tunica media and tunica adventitia of the arterial wall, leading to the formation of a pseudoaneurysm[18,19].

Direct invasion

Rupture into nearby structures is one of the most common complications of LA[4]. LAs of the left lobe and the caudate lobe are more vulnerable to cardiovascular complications due to their proximity to the heart and major vessels. ALA has been reported to directly invade the IVC[15,17]. Concomitant injury to the bile ducts and HV may cause a biliovascular fistula, which raises serum bilirubin levels rapidly[27].

SPECTRUM OF VASCULAR COMPLICATIONS AND CLINICAL PRESENTATION

The spectrum of vascular complications in LA patients is depicted in Figure 1. It includes the following:

Figure 1
Figure 1 Spectrum of vascular complications associated with liver abscess. IVC: Inferior vena cava; HAPA: Hepatic artery pseudoaneurysm; PTE: Pulmonary thromboembolism.
Vascular compression

The complication due to vascular compression is more common with large LAs located in the caudate lobe (Figure 2). Huddle et al[16] and Sharma et al[21] reported a case of caudate lobe ALA causing extrinsic compression of the IVC without evidence of thrombosis. Mehrotra et al[28] reported a large staphylococcal PLA causing IVC compression and presenting as acute Budd-Chiari syndrome (BCS). Karadag et al[29] have also reported a case of PLA compressing the IVC and HVs, causing acute BCS.

Figure 2
Figure 2 Axial contrast-enhanced computed tomography image showing a large ruptured amebic liver abscess (asterisk) in the caudate lobe, exerting pressure on the inferior vena cava (arrow). Note the fluid collection in perihepatic space resulting from the ruptured abscess.
Venous thrombosis

Venous thrombosis contributes to the intricate cardiovascular landscape associated with LA (Figure 3). The reported frequency of thrombotic consequences varies widely, from 3.7% to as high as 69%[14,28,30]. Venous thrombosis has been reported in LAs of both amebic and pyogenic origin (Tables 1 and 2).

Figure 3
Figure 3 Venous thrombosis in associations with liver abscess. A: Axial contrast-enhanced computed tomography (CT) imaging illustrates the presence of thrombosis within the inferior vena cava (black arrow) and the right hepatic vein (white arrow) in a patient with abscess in right lobe of liver; B: Axial contrast-enhanced CT scan demonstrates the presence of a thrombus within the right posterior segmental branch of the right portal vein in a patient with liver abscess; C: Coronal contrast-enhanced CT imaging depicts thrombosis occurring in the segmental branch of the right portal vein in a patient with liver abscess.
Table 1 The vascular thrombotic complications in association with amebic liver abscess.
Ref.
Study type
Vascular complication
Age /gender
LA size & site
Treatment
Outcomes
Sarda et al[32], 2010, IndiaCase series, n = 3IVC thrombosis21, 24, and 61 years/MLarge, caudate lobeAntibiotics and PDComplete resolution
Jesrani et al[43], 2020, IndiaCase reportPTE26 years/MLarge, segment VIIIAntibiotics, PD, and anticoagulationStable clinical improvement
Sodhi et al[34], 2007, IndiaCase reportHepatic vein and IVC thrombosis57 years/MLarge, right lobeAntibiotics, PD, and anticoagulationContinued improvement
Martin et al[26], 2017, CanadaCase reportIVC and hepatic vein thrombosis43 years/MLarge, caudate lobeAntibioticsStable clinical improvement
Gupta et al[72], 2013, IndiaCase reportIVC thrombosis6 years/MSmall, left lobeAntibiotics + surgical thrombectomyComplete resolution
Khan et al[73], 2009, PakistanCase reportIVC and right atrium thrombus46 years/MLarge, right lobeAntibiotics, PD, anticoagulation, and surgical thrombectomyComplete recovery
Prendki et al[9], 2011, FranceCase reportIVC and right atrial thrombosis, and PTE23 years/MLarge, right lobeAntibiotics, PD, and anticoagulationContinued clinical improvement
McKenzie et al[10], 2015, United StatesCase reportIVC and HV thrombosis, PTE43 years/MLarge, left lobeAntibiotics and anticoagulationStable clinical improvement
Goel et al[53], 2020, IndiaCase reportBilhaemia, PVT, and HVT64 years/MLarge, segment IVAntibiotics, PD, and anticoagulation + biliary stentingComplete improvement
Marak et al[17], 2023, IndiaCase series, n = 3IVC thrombosis38, 55 & 56 years/MLarge, both lobeAntibiotics and PDStable improvement
Siddiqui et al[64], 2013, IndiaCase reportIVC and right atrial thrombus2 years/MLarge, segment IV/VIIIAntibiotics, surgery, anticoagulationComplete resolution of abscess
Ray et al[70], 2012, IndiaCase reportIVC thrombosis47 years/MLarge, right lobeAntibiotics and PDUneventful recovery
Méchaï et al[65], 2009, FranceCase reportHVT (Budd-Chiari syndrome)87 years/MLarge, right lobeAntibiotics, PD, and anticoagulationProgressive recovery
Thati and Nagral[66], 2014, IndiaCase reportIVC thrombosis with PTE50 years/MLarge, segment VIIIAntibiotics, PD, and anticoagulationComplete improvement
Priyadarshi et al[14], 2020, IndiaProspective cohort, n = 62Venous thrombosis in 43 (69%), including PVT, HVT and IVC thrombosisMean age 37 years/M 95%Mean size 95 cm, both lobesAntibiotics and PDPartial resolution of thrombus and segmental atrophy of liver in 5 patients after 2 months
Table 2 The vascular thrombotic complications in association with pyogenic liver abscess.
Ref.
Study, patient (s)
Types of vascular complications
Demographics
PLA size and location
Treatment
Outcomes
Syed et al[35], 2007, CanadaRetrospective study, PLA, n = 67PVT (24%) and HVT (22%)Mean age 55 years, male 80%Mean, 8.5 cm, mainly right lobeStandard treatment, detail NAThrombosis resolved in 37% within 6 months
Trad et al[67], 2022, United StatesCase report, PLAPylephlebitis (PVT)49 years male5 cm × 3.5 cm, right lobeAntibiotics and anticoagulationComplete recovery
Molton et al[40], 2015 SingaporeRetrospective study, n = 169 KLARegional vein thrombosisMedian age 58 years, 71% male Mean abscess size 67cm, both lobeAntibiotics, drainage in 77% patients, anticoagulation in one patientComplete recanalization in 73.2% cases, death in 3.6% patients
Wang et al[36], 2013 TaiwanRetrospective study, n = 35, KLAPylephlebitisMedian age 57, 83% maleNAAntibioticsLonger hospital stay, but no mortality
Kubo et al[41], 2017, JapanCase report, PLA (Morganella morganii)PVT and Superior mesenteric vein thrombosis59 years/malePLA in segment VIIIAntibiotics, anticoagulants and surgery for diverticulitisStable clinical improvement
Güz et al[37], 2006, TurkeyCase report, PLA (Lactococcus lactis)PVT26 years/male17 cm × 11 cm × 11 cm PLA, right lobeAntibiotics, PD, and anticoagulantsPersistent PVT till 6 months
Shah and Bhatnagar[44], 2009, IndiaCase report, PLAPVT and portal cavernoma20-day neonate5.1 cm × 5.8 cm PLA, right lobeAntibiotics, surgical drainageStable improvement
Aggarwal et al[45], 2003, IndiaCase report, PLA (Staphylococcus aureus)PVT and portal cavernoma28-day, neonate5 cm × 4 cm PLA, right lobeAntibioticsStable improvement
Etienne et al[68], 2001, AustraliaCase report, PLA (Fusobacterium nucleatum)Pylephlebitis (PVT)68 years/male3-cm × 5-cm PLA, right lobeIV antibiotics, anticoagulantsComplete resolution
Zhou et al[42], 2022, ChinaCase report, KLACerebral venous sinus thrombosis54 years/maleMultiple abscess, largest 59 mm × 49 mm, right lobeAntibiotics, anticoagulantsClinical improvement, no significant change in cerebral sinus thrombosis
Ogah et al[39], 2012, United KingdomCase report, PLA (Clostridium clostridioforme)PVT6 years/FMultiple PLAAntibiotics and PDComplete recovery
Bagri et al[56], 2013, IndiaCase report, PLAIVC and right atrial thrombosis2 years 9 month boy5 cm × 4.8 cm × 5.8 cm, right lobeAntibiotics and surgeryGradual complete improvement
Linsen et al[69], 2023, NetherlandsCase report, PLA (Escherichia coli and Fusobacteriumspp)Pylephlebitis42 years/maleMultiple abscesses, right lobeAntibiotics, anticoagulantsGradual improvement with complete resolution of abscess
Mehrotra et al[28], 1991, IndiaCase report, PLA (Staphylococcus aureus)Acute Budd Chiari, IVC thrombosis6 years/maleRight lobe liver abscessAntibiotics and Surgical drainageComplete recovery
Maffiolo et al[71], 2006, FranceCase series, KLAThrombophlebitis of HV42 and 55, maleMultiple abscesses right lobeAntibiotics and PDComplete improvement

Venous thrombosis in ALA patients: Krishnan et al[15] found IVC thrombosis in 8% of cases and HVT in all but one of the 95 ALA patients in a comprehensive autopsy study. In another autopsy series, Aikat et al[31] reported PVT in 27.5%, HVT in 29.5%, and IVC thrombosis in 4% of ALA cases. Sarda et al[32] reported three cases of ALA-induced IVC obstruction that was resolved after percutaneous drainage and antibiotic treatment. Three cases of ALA extending into the IVC and causing its thrombosis were recently reported by Marak et al[17]. Hodkinson et al[33] reported another case of a 50-year-old man with ALA who developed an IVC thrombus that spread to the right atrium. Sodhi et al[34] reported a 57-year-old man whose ALA was complicated by HVT and IVC thrombosis.

Venous thrombosis in PLA patients: In a study by Syed et al[35], 28 out of 67 patients (42%) with PLA had venous thrombosis. PVT was present in 24%, HVT in 22%, and combined PVT + HVT in 4% of patients. Venous thrombosis resolved in 37% of 27 patients after 6 months and persisted in 63% during the 3- to 38-month follow-up period. Yang et al[30], in a retrospective analysis of 81 PLA patients, reported PVT in three patients (3.7%), and one patient also had extrinsic compression of the IVC. In a study, PLA due to Klebsiella pneumoniae was identified as the most common (37%) cause of thrombophlebitis of the portal venous system (pylephlebitis)[36]. PLA due to various other bacterial causes such as Lactococcus lactis, Fusobacterium nucleatum, and Clostridium clostridioforme has been reported to be complicated by PVT[37-39]. In a retrospective analysis of 169 patients with Klebsiella pneumoniae-associated PLA, Molton et al[40] found that 53 patients (31.4%) had thrombophlebitis of the PV or HV. In follow-up scans, 73% (30/49) of patients showed spontaneous recanalization in a mean duration of 44 days. Thrombosis of the cerebral venous sinus and superior mesenteric vein has also been reported in association with PLA[41,42].

Clinical consequences of vascular obstruction

Thrombosis of segmental hepatic vessels appears to aggravate the severity of LA. Priyadarshi et al[14] found that hepatic ischemia caused by venous thrombosis increased the severity of LA, and more patients with hepatic ischemia experienced an aggressive clinical course necessitating interventional therapy. LA patients with IVC thrombosis are at risk of thromboembolic phenomena. Several studies, including those by Prendki et al[9], McKenzie et al[10], and Jesrani et al[43], have reported cases of ALA complicated by pulmonary thromboembolism. A high index of suspicion is required to diagnose these complications in LA patients who might have hemodynamic instability and respiratory distress. Thrombosis of the HV and IVC may introduce additional signs such as pedal edema, ascites, and hepatomegaly, indicating possible venous congestion and impaired venous return. Thus, LA can rarely result in the development of secondary BCS. The development of portal hypertension poses an additional challenge and reflects the systemic impact of a complicated LA. There are many reports of neonatal PLA complicated by PVT with subsequent formation of portal cavernoma[44-46]. Shah et al[44] reported the appearance of PVT in a neonate after 16 days of treatment for LA, who subsequently developed portal hypertension. Aggarwal et al[45] and Sethi et al[46] also reported PVT and cavernoma in association with neonatal PLA. One key clinical indicator that points to the presence of PVT in patients with LA is unexplained abdominal pain, particularly if it is severe and persistent. Patients with pylephlebitis may develop severe sepsis, including septic shock and decreased cognitive function.

HAPA

HAPA, although uncommon, are the second most prevalent type of pseudoaneurysm involving the splanchnic artery. They are usually extrahepatic in location (75%) and traumatic in origin[47]. Nonetheless, HAPA, in association with LA, are generally intrahepatic and can also be intracavitary (Figure 4). HAPA have been reported more often in association with ALA than PLA (Table 3). The first incidence of HAPA linked to an ALA was reported by Gopanpallikar et al[48] in 1997. Silvestri et al[49] reviewed 6 cases of HAPA associated with ALA. The mean age of patients was 44.8 ± 8 years, and all were male. The most common presentation was fever, abdominal pain, and GI bleeding. The aneurysm ruptured in two cases, while it regressed spontaneously in two others after treating ALA. With available follow-up data in 5 patients, all had uneventful recoveries. Qi et al[50] reported HAPA in association with PLA due to Listeria monocytogenes in a 50-year-old woman. While HAPA may be asymptomatic in patients with LA, symptoms such as persistent abdominal pain, bleeding manifestations, or signs of hemodynamic instability should raise suspicions about this complication. Rupture of the HAPA into the biliary system can lead to hemobilia presenting as GI bleeding[18,51]. Importantly, in patients with ALA, concurrent ileo-colonic ulcerations caused by amebic trophozoites frequently result in GI hemorrhage[52]. Early detection and prompt management of HAPA are important, considering that its complications are catastrophic.

Figure 4
Figure 4 Computed tomography scan image of hepatic artery pseudoaneurysm in association with liver abscess. A: Axial image demonstrating a small aneurysm (arrow) originating from a peripheral branch of the right hepatic artery within the abscess cavity (asterisk); B: Coronal computed tomography image of the same patient demonstrating the hepatic artery pseudoaneurysm.
Table 3 Hepatic artery pseudoaneurysm associated with amebic and pyogenic liver abscess.
Ref.
Study type
Age/gender
LA type
Complication
Treatment
Outcomes
Silvestri and Ngasala[49], 2022, TanzaniaCase review, n = 6Mean age 448 yearsALAHAPAIV antibiotics and aneurysm embolization in 3 casesUneventful recovery in 5 patients
Priyadarshi et al[19], 2019, IndiaCase report52 years/MALARight HAPA (10 mm) with
hemobilia
Antibiotics and PDComplete resolution
Tacconi et al[75], 2009, ItalyCase report31 years/MALARight HAPA (15 mm)Antibiotics and needle aspiration of ALAComplete resolution
Yadav et al[51], 2015, IndiaCase report45 years/MALAHAPA with hemobiliaAntibiotics, PD of ALA and percutaneous glue embolizationUneventful recovery
Kang et al[18], 2006, IndiaCase report58 years/FALARight HAPA (15 mm) with rupture into abscessPD of ALA + Coil embolizationComplete resolution
Qi et al[50], 2023, United StatesCase report50 years/FPLAHAPAIV antibiotics and PDComplete improvement
Lee et al[74], 2020, KoreaCase report80 years/MPLAHAPAIV antibiotics, PD and percutaneous embolizationComplete resolution
Other vascular complications

On rare occasions, LA can lead to an intrahepatic connection between the biliary and venous systems, resulting in the mixing of bile and contents of the LA with blood in low-pressure intrahepatic veins. This leads to a rapid increase in the levels of bilirubin and bile acids in serum. Thus, biliovascular fistula is a unique and uncommon consequence of LA that may have significant clinical implications[27,53]. Singh et al[27] described the occurrence of biliovascular fistula in 12 ALA patients with hyperbilirubinemia. Interestingly, following biliary diversion with nasobiliary drainage, the hyperbilirubinemia in these patients returned to normal.

The heart is a vital component of the vascular system. Due to its proximity to the liver’s left lobe, the heart may get involved in complicated left lobe LA. As rupture is a common complication of ALA, cardiac tamponade may result from the rupture of the left lobe of ALA into the pericardium[35,36]. PLA due to Actinomyces, which is a gram-positive anaerobic to microaerophilic bacterium, has been associated with purulent pericarditis with cardiac tamponade[54,55]. The presence of dyspnea, tachycardia, hypotension, and pulsus paradoxus can raise suspicions about this life-threatening complication of LA. Early diagnosis of this condition is necessary to avoid adverse outcomes. Rarely, right heart failure can occur in patients with LA due to a right atrial thrombus[56].

MANAGEMENT ISSUES: DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS

The initial presentation of LA with vascular involvement may be similar to that of uncomplicated LA. However, when LA patients develop persistent or worsening abdominal symptoms, ascites or pedal edema, gastrointestinal bleeding, dyspnea, or hemodynamic instability, vascular complications should be suspected. Appropriate imaging modalities should be used to diagnose these complications to enable timely intervention and improved patient outcomes. Doppler ultrasound can be the initial imaging modality to diagnose PVT. It has the advantages of being non-invasive, widely available, and good sensitivity to detect flow abnormalities in the PV. However, its role may be limited in patients with obesity or extensive thrombosis. More sophisticated imaging methods like multidetector CT angiography and magnetic resonance angiography provide better diagnostic precision and spatial resolution for identifying PVT and/or HVT and evaluating their severity and associated complications[57,58]. By providing a thorough assessment of collateral circulation, vascular patency, and cavernous changes, these modalities can aid in prognostication and therapeutic decision-making. Regarding HAPA, CT angiography is valuable for detecting, characterizing, and guiding treatment decisions[19,51]. Contrast-enhanced ultrasonography (CEUS) is a valuable diagnostic tool for LAs. It can also be used to differentiate LAs from other liver masses, characterize LAs, which may help with treatment decisions, and guide percutaneous catheter or needle drainage[59,60]. On CEUS, LAs commonly exhibit rim enhancement, a nonenhanced central necrotic region, enhanced internal septa, and transiently hyperenhanced liver parenchyma surrounding the lesions[61]. Treatment under Sonovue CEUS is associated with faster recovery, better treatment response, and a lower risk of complications in PLA patients[59].

Vascular complications of LA are managed through a multidisciplinary approach that considers multiple host- and disease-related factors. To navigate the intricacies of this clinical circumstance and provide optimal patient care, hepatologists, interventional radiologists, and surgeons must collaborate. Prompt initiation of antibiotic therapy targeting probable microorganisms is essential to treat the underlying abscess; typically, drugs like metronidazole are combined with cephalosporins or fluoroquinolones.[59] Image-guided percutaneous catheter drainage (PCD) of the abscess is crucial to eliminate the infectious source. Drainage is important because it facilitates better penetration of antibiotics and clears necrotic material, bile, and blood clots that delay the abscess cavity healing[62]. The routine use of anticoagulant medication for venous thrombosis in the setting of LA continues to be debated. The benefits of preventing thrombus propagation must be weighed against the risk of hemorrhagic complications[63]. Anticoagulation therapy resolves venous thrombosis associated with both ALA[64-66] and PLA[67-69]. Nevertheless, many reports document spontaneous recanalization of vascular thrombosis after proper treatment of LA alone[30,63,70,71]. Surgical thrombectomy has also been performed in some cases; however, such aggressive treatment is often unnecessary[72,73]. Sarda et al[32] reported recanalization of IVC obstruction in three ALA patients treated with percutaneous drainage and antibiotic therapy. Molton et al[40] reported spontaneous recanalization of vascular thrombosis in the majority (73%) of affected PLA patients without anticoagulant therapy. This implies that the underlying abscess should be the focus of treatment, rather than the thrombus. However, therapeutic anticoagulation should be considered in cases of severe IVC thrombosis, right atrial thrombus, or thromboembolism.

HAPA can be treated with endovascular embolization, surgical resection, or close observation. Due to its rarity and the paucity of knowledge thereof, there is still no consensus on the best treatment approach. Given the significant morbidity associated with surgical treatment, percutaneous trans-arterial embolization is currently recommended for intrahepatic aneurysms[18,51,74]. Metallic coils, non-absorbable polyvinyl alcohol particles, or liquid embolic agents like N-butyl cyanoacrylate are the most common types of embolic agents used. Coils are the most commonly used embolic agent when vascular anatomy is favorable. Nevertheless, with appropriate treatment of LA using antibiotics and PCD, spontaneous resolution of HAPA is possible[19,50,75]. Which patients should be chosen for expectant treatment is unclear. A small HAPA (< 2 cm) arising from the peripheral branch of the HA may resolve spontaneously[19]. Repeated ultrasonography with Doppler can help clinicians monitor these patients while adhering to expectant treatment. For patients with pericardial rupture of LA, immediate pericardiocentesis is the cornerstone of treatment[12]. LA complicated by biliovascular fistula may respond to biliary diversion using nasobiliary drainage[27].

Thus, many of vascular complications require care of only LA with antimicrobials and percutaneous drainage. Ultrasound guided percutaneous drainage of LA is quite safe procedure. No major complication related to PCD or needle aspiration have been reported in patients with either PLA or ALA[1,76-78]. The requirement of additional treatment will depend on the nature, severity and course of vascular complication.

UNUSUAL CAUSES OF LIVER ABSCESS

Occasional causes of LA include mycobacteria and fungi[79]. Sometimes, suppuration of cystic hepatic diseases, such as hydatid cysts, can also result in LA. In a cross-sectional study from India (n = 200), the etiology of LA was mycobacteria in 7.5% and candida in 1.5% of 200 consecutive LA patients[79]. Fungal liver abscesses can occur in onco-hematologic patients and hematopoietic stem cell transplantation recipients[80]. Generally, fungal liver infections are caused by Candida species. Little information is available about vascular involvement in fungal LA. Paccoud et al[81] reported a case of chronic LA with PVT caused by Candida. Liver involvement is possible in endemic areas of tuberculosis; however, the presentation of hepatic tuberculosis as focal LA is extremely uncommon[82,83]. In a study, tubercular LA was found in the left liver lobe and smear positive for acid-fast bacilli. PVT has also been associated with hepatic tuberculosis rarely[84,85]. These cases have been successfully treated with antituberculosis medications and an anticoagulant[85]. A hepatic hydatid cyst can sometimes masquerade as LA[86]. Particularly, secondary bacterial infection of a hydatid cyst makes it difficult to differentiate from a PLA. In a large series of hepatic hydatid cysts, suppuration occurred in 7 of 328 cases (2.1%)[87]. Although vascular involvement in the form of PVT and secondary BCS has been reported in cases of hepatic hydatid disease, no literature has specifically detailed this complication vis-a-vis an infected hydatid cyst[88-90].

CONCLUSION

Vascular complications due to LA occur with varying frequencies[14,19,28,30,91]. They include mainly thrombosis of PV, HV, IVC, and rarely HAPA; direct rupture into major vessels and pericardium; and biliovascular fistula. These vascular complications can increase morbidity and may cause mortality among affected patients. Mortality is usually associated with rare but serious complications such as septic shock, pulmonary thromboembolism, and cardiac tamponade. Suspicion of vascular complications should be high if patients with LA show persistent, worsening, or new symptoms, despite receiving the recommended antibiotic therapy. Hemodynamically unstable patients might need immediate imaging to rule out life-threatening complications. Vascular problems may not show up on traditional ultrasound imaging, necessitating abdominal CT or MRI with angiography. The majority of vascular complications resolve with antibiotics and drainage of LA. Drainage is particularly necessary in large LAs, which are more likely to cause vascular complications. Abdominal ultrasonography is generally used to guide percutaneous drainage. Serial ultrasound examinations can be useful in monitoring therapeutic responses, besides clinical signs. The requirement for additional treatment will depend on the nature, severity, and course of the vascular complication. Thrombotic complications appear to resolve with treatment of LA alone, and anticoagulation is not necessary. Nonetheless, a small proportion of PVT patients, especially those diagnosed early in life, may develop chronic portal hypertension. Thus, individualized treatment and vigilant monitoring are required to ensure favorable patient outcomes. Additional research is necessary to shed more light on the risk factors and natural history of vascular complications, the appropriate timing and indication of intervention, and ways to prevent such complications.

Footnotes

Provenance and peer review: Invited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Gastroenterology and hepatology

Country of origin: India

Peer-review report’s classification

Scientific Quality: Grade C, Grade D

Novelty: Grade B, Grade C

Creativity or Innovation: Grade B, Grade C

Scientific Significance: Grade B, Grade C

P-Reviewer: Giorgio A S-Editor: Liu JH L-Editor: A P-Editor: Zhang L

References
1.  Priyadarshi RN, Kumar R, Anand U. Amebic liver abscess: Clinico-radiological findings and interventional management. World J Radiol. 2022;14:272-285.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.5]  [Reference Citation Analysis (1)]
2.  Akhondi H, Sabih DE.   Liver Abscess. 2023 Jul 3. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Grassel M, Yim D, Shriver J, Redlin T. Increased Incidence of Pyogenic Liver Abscess in a Midwest System With Emphasis on Rural Impact. Cureus. 2022;14:e21477.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
4.  Kumar R, Patel R, Priyadarshi RN, Narayan R, Maji T, Anand U, Soni JR. Amebic liver abscess: An update. World J Hepatol. 2024;16:316-330.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (2)]
5.  Singh A, Banerjee T, Khan U, Shukla SK. Epidemiology of clinically relevant Entamoeba spp. (E. histolytica/dispar/moshkovskii/bangladeshi): A cross sectional study from North India. PLoS Negl Trop Dis. 2021;15:e0009762.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 2]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
6.  Kaplan GG, Gregson DB, Laupland KB. Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess. Clin Gastroenterol Hepatol. 2004;2:1032-1038.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 180]  [Cited by in F6Publishing: 179]  [Article Influence: 9.0]  [Reference Citation Analysis (0)]
7.  Lorente S, Hautefeuille M, Sanchez-Cedillo A. The liver, a functionalized vascular structure. Sci Rep. 2020;10:16194.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 31]  [Article Influence: 7.8]  [Reference Citation Analysis (0)]
8.  DeLeve LD, Valla DC, Garcia-Tsao G; American Association for the Study Liver Diseases. Vascular disorders of the liver. Hepatology. 2009;49:1729-1764.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 739]  [Cited by in F6Publishing: 614]  [Article Influence: 40.9]  [Reference Citation Analysis (0)]
9.  Prendki V, Stirnemann J, Pham I, Poignard P, Le Henaff L, Houze S, Sellier N, Fain O. Amebic liver abscess, extensive thrombosis, and patent cardiac foramen ovale. J Travel Med. 2011;18:427-429.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 3]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
10.  McKenzie D, Gale M, Patel S, Kaluta G. Pulmonary Thromboembolism Complicating Amebic Liver Abscess: First Reported Case in the United States-Case Report and Literature Review. Case Rep Infect Dis. 2015;2015:516974.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 5]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
11.  Ibarra-Pérez C. Thoracic complications of amebic abscess of the liver: report of 501 cases. Chest. 1981;79:672-677.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 80]  [Cited by in F6Publishing: 84]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
12.  Francis C, Soni S, Gupta A, Agstam S. A case report of ruptured amoebic liver abscess causing cardiac tamponade and requiring pericardial window. Eur Heart J Case Rep. 2020;4:1-4.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 3]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
13.  Jindal A, Pandey A, Sharma MK, Mukund A, Vijayaraghavan R, Arora V, Shasthry SM, Choudhary A, Sarin SK. Management Practices and Predictors of Outcome of Liver Abscess in Adults: A Series of 1630 Patients from a Liver Unit. J Clin Exp Hepatol. 2021;11:312-320.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 10]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
14.  Priyadarshi RN, Kumar P, Kumar R, Anand U, Shyama. Venous thrombosis and segmental hypoperfusion in amebic liver abscess: MDCT demonstration and its implications. Abdom Radiol (NY). 2020;45:652-660.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 5]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
15.  Krishnan K, Badarinath S, Bhusnurmath SR. Vascular complications of hepatic amoebiasis--a retrospective study. Indian J Pathol Microbiol. 1986;29:293-296.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Huddle KR. Amoebic liver abscess, inferior vena-caval compression and the nephrotic syndrome. A case report. S Afr Med J. 1982;61:758-760.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Marak JR, Raj G, Narayan S, Gara H, Das P. Liver abscess with extension into the Inferior Vena Cava: Case series of a rare complication. Radiol Case Rep. 2024;19:594-599.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
18.  Kang M, Bapuraj JR, Khandelwal N, Kochhar R, Kalra N, Verma GR. Liver abscess associated with hepatic artery pseudoaneurysm with arteriovenous fistula: imaging and interventional management. Acta Radiol. 2006;47:162-166.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 5]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
19.  Priyadarshi RN, Kumar R, Anand U. Case Report: Spontaneous Resolution of Intracavitary Hepatic Artery Pseudoaneurysm Caused by Amebic Liver Abscess following Percutaneous Drainage. Am J Trop Med Hyg. 2019;101:157-159.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 7]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
20.  Yadav T, Patel RK, Bansal A, Chatterjee N, Patidar Y, Mukund A. Caudate lobe amebic abscesses: percutaneous image-guided aspiration or drainage. Abdom Radiol (NY). 2022;47:1157-1166.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
21.  Sharma MP, Sarin SK. Inferior vena caval obstruction due to amoebic liver abscess. J Assoc Physicians India. 1982;30:243-244.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Kalogeris T, Baines CP, Krenz M, Korthuis RJ. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012;298:229-317.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1400]  [Cited by in F6Publishing: 1405]  [Article Influence: 117.1]  [Reference Citation Analysis (0)]
23.  Dolmatova EV, Wang K, Mandavilli R, Griendling KK. The effects of sepsis on endothelium and clinical implications. Cardiovasc Res. 2021;117:60-73.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 109]  [Cited by in F6Publishing: 112]  [Article Influence: 37.3]  [Reference Citation Analysis (0)]
24.  Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9:7204-7218.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2209]  [Cited by in F6Publishing: 2464]  [Article Influence: 410.7]  [Reference Citation Analysis (0)]
25.  Colling ME, Tourdot BE, Kanthi Y. Inflammation, Infection and Venous Thromboembolism. Circ Res. 2021;128:2017-2036.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 96]  [Cited by in F6Publishing: 123]  [Article Influence: 41.0]  [Reference Citation Analysis (0)]
26.  Martin L, Burute N, Haider E, Serrano PE, O'Shea T, Siegal D. Occult Amebic Liver Abscess as Cause of Extensive Inferior Vena Cava and Hepatic Vein Thrombosis. Am J Trop Med Hyg. 2017;97:1214-1217.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 9]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
27.  Singh V, Bhalla A, Sharma N, Mahi SK, Lal A, Singh P. Pathophysiology of jaundice in amoebic liver abscess. Am J Trop Med Hyg. 2008;78:556-559.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Mehrotra G, Singh RP, Krishna A, Singh BK. Pyogenic liver abscess causing acute Budd-Chiari syndrome. Ann Trop Paediatr. 1992;12:451-453.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
29.  Karadag O, Akinci D, Aksoy DY, Bayraktar Y. Acute Budd-Chiari syndrome resulting from a pyogenic liver abscess. Hepatogastroenterology. 2005;52:1554-1556.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Yang DM, Kim HN, Kang JH, Seo TS, Park CH, Kim HS. Complications of pyogenic hepatic abscess: computed tomography and clinical features. J Comput Assist Tomogr. 2004;28:311-317.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 14]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
31.  Aikat BK, Bhusnurmath SR, Pal AK, Chhuttani PN, Datta DV. The pathology and pathogenesis of fatal hepatic amoebiasis--A study based on 79 autopsy cases. Trans R Soc Trop Med Hyg. 1979;73:188-192.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 40]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
32.  Sarda AK, Mittal R, Basra BK, Mishra A, Talwar N. Three cases of amoebic liver abscess causing inferior vena cava obstruction, with a review of the literature. Korean J Hepatol. 2011;17:71-75.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 12]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
33.  Hodkinson J, Couper-Smith J, Kew MC. Inferior vena caval and right atrial thrombosis complicating an amebic hepatic abscess. Am J Gastroenterol. 1988;83:786-788.  [PubMed]  [DOI]  [Cited in This Article: ]
34.  Sodhi KS, Ojili V, Sakhuja V, Khandelwal N. Hepatic and inferior vena caval thrombosis: vascular complication of amebic liver abscess. J Emerg Med. 2008;34:155-157.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 28]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
35.  Syed MA, Kim TK, Jang HJ. Portal and hepatic vein thrombosis in liver abscess: CT findings. Eur J Radiol. 2007;61:513-519.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 34]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
36.  Wang YF, Chang CC, Lee TC, Shih IL, Lien WC, Chen SJ, Wang HP, Liu KL. Recent trend of pylephlebitis in Taiwan: Klebsiella pneumoniae liver abscess as an emerging etiology. Infection. 2013;41:1137-1143.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 12]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
37.  Güz G, Yeğin ZA, Doğan I, Hizel K, Bali M, Sindel S. Portal vein thrombosis and liver abscess due to Lactococcus lactis. Turk J Gastroenterol. 2006;17:144-147.  [PubMed]  [DOI]  [Cited in This Article: ]
38.  Rahmati E, She RC, Kazmierski B, Geiseler PJ, Wong D. A case of liver abscess and fusobacterium septicemia. IDCases. 2017;9:98-100.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 14]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
39.  Ogah K, Sethi K, Karthik V. Clostridium clostridioforme liver abscess complicated by portal vein thrombosis in childhood. J Med Microbiol. 2012;61:297-299.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 6]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
40.  Molton JS, Chee YL, Hennedige TP, Venkatesh SK, Archuleta S. Impact of Regional Vein Thrombosis in Patients with Klebsiella pneumoniae Liver Abscess. PLoS One. 2015;10:e0140129.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 10]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
41.  Kubo H, Asai G, Haraguchi K, Shibahara Y, Kihara T, Yamakawa G, Kira F, Higashi H, Morishita S, Fujie H, Matsumoto M, Shimura W. Liver Abscess and Portal Vein Thrombosis Due to Ileal Diverticulitis Mediated by Barium Fluoroscopy. Intern Med. 2017;56:3255-3259.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 2]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
42.  Zhou L, Wang C, Bian J, Xu S, Yang M, Chen M. Cerebral venous sinus thrombosis in a patient with Klebsiella pneumoniae primary liver abscess: a case report. BMC Neurol. 2022;22:286.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
43.  Jesrani G, Gupta S, Gupta M, Gaba S, Naveen V. Pulmonary Thromboembolism: A Rare Vascular Complication of Amebic Liver Abscess. Cureus. 2020;12:e10872.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
44.  Shah I, Bhatnagar S. Liver abscess in a newborn leading to portal vein thrombosis. Indian J Pediatr. 2009;76:1268-1269.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 13]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
45.  Aggarwal S, Mathur NB, Garg A. Portal vein thrombosis complicating neonatal hepatic abscess. Indian Pediatr. 2003;40:997-1001.  [PubMed]  [DOI]  [Cited in This Article: ]
46.  Sethi SK, Dewan P, Faridi MM, Aggarwal A, Upreti L. Liver abscess, portal vein thrombosis and cavernoma formation following umbilical vein catherisation in two neonates. Trop Gastroenterol. 2007;28:79-80.  [PubMed]  [DOI]  [Cited in This Article: ]
47.  Christensen T, Matsuoka L, Heestand G, Palmer S, Mateo R, Genyk Y, Selby R, Sher L. Iatrogenic pseudoaneurysms of the extrahepatic arterial vasculature: management and outcome. HPB (Oxford). 2006;8:458-464.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 17]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
48.  Gopanpallikar A, Rathi P, Sawant P, Gupta R, Dhadphale S, Deshmukh HL. Hepatic artery pseudoaneurysm associated with amebic liver abscess presenting as upper GI hemorrhage. Am J Gastroenterol. 1997;92:1391-1393.  [PubMed]  [DOI]  [Cited in This Article: ]
49.  Silvestri V, Ngasala B. Hepatic aneurysm in patients with amoebic liver abscess. A review of cases in literature. Travel Med Infect Dis. 2022;46:102274.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
50.  Qi X, Tamizuddin S, Gisi B, Lee P. Multiple liver abscesses secondary to Listeria monocytogenes complicated by hepatic artery mycotic aneurysm. BMJ Case Rep. 2023;16.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
51.  Yadav AK, Gupta S, Hariprasad S, Kumar A, Ghuman SS, Gupta A. Amoebic liver abscess with hepatic artery pseudoaneurysm: successful treatment by interventional radiology. J Clin Exp Hepatol. 2015;5:86-88.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 6]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
52.  Premkumar M, Devurgowda D, Dudha S, Kulkarni A, Joshi YK. Clinical and Endoscopic Management of Synchronous Amoebic Liver Abscess and Bleeding Colonic Ulcers. J Assoc Physicians India. 2019;67:14-18.  [PubMed]  [DOI]  [Cited in This Article: ]
53.  Goel R, Roy A, Ray D, Chaluvashetty SB, De A. A case of amoebic liver abscess complicated by bilhaemia and venous thrombosis. Trop Doct. 2021;51:249-250.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
54.  Sakaguchi Y, Isowa N, Nakazaki H, Takeda K, Tokuyasu H, Saitoh Y, Soeda T, Ohe T, Tokuyasu Y, Miura H. Acute cardiac tamponade caused by the extension of multiple hepatic actinomycotic abscesses. Intern Med. 2012;51:305-308.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 6]  [Cited by in F6Publishing: 6]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
55.  Llenas-García J, Lalueza-Blanco A, Fernández-Ruiz M, Villar-Silva J, Ochoa M, Lozano F, Lizasoain M, Aguado JM. Primary hepatic actinomycosis presenting as purulent pericarditis with cardiac tamponade. Infection. 2012;40:339-341.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 6]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
56.  Bagri N, Yadav D, Hemal A. Inferior vena caval and right atrial thrombosis: complicating pyogenic liver abscess. Indian Pediatr. 2013;50:701-703.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 4]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
57.  Firat A, Abbasoglu TT, Karcaaltincaba M, Balaban YH. Clinical anatomy of hepatic vessels by computed tomography angiography: A minireview. World J Radiol. 2023;15:1-9.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
58.  Laissy JP, Trillaud H, Douek P. MR angiography: noninvasive vascular imaging of the abdomen. Abdom Imaging. 2002;27:488-506.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 86]  [Cited by in F6Publishing: 91]  [Article Influence: 4.1]  [Reference Citation Analysis (0)]
59.  Ming Y, Wei H, Zhang Y, Gao G, Deng B, Huang L, Wang Q, Zheng X, Luo X. The Effect of Contrast-enhanced Ultrasound via Vessels and Surgical Drains Guidance Percutaneous Catheter Drainage in the Treatment of Pyogenic Liver Abscess. Curr Med Imaging. 2024;.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
60.  Kunze G, Staritz M, Köhler M. Contrast-enhanced ultrasound in different stages of pyogenic liver abscess. Ultrasound Med Biol. 2015;41:952-959.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 12]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
61.  Popescu A, Sporea I, Şirli R, Dănilă M, Mare R, Grădinaru Taşcău O, Moga T. Does Contrast Enhanced Ultrasound improve the management of liver abscesses? A single centre experience. Med Ultrason. 2015;17:451-455.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 20]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
62.  Lübbert C, Wiegand J, Karlas T. Therapy of Liver Abscesses. Viszeralmedizin. 2014;30:334-341.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 52]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
63.  Scarlatescu E, Tomescu D, Arama SS. Anticoagulant Therapy in Sepsis. The Importance of Timing. J Crit Care Med (Targu Mures). 2017;3:63-69.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 8]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
64.  Siddiqui M, Gupta A, Kazmi A, Chandra D, Grover V, Gupta V. Inferior vena caval and right atrial thrombus complicating amoebic liver abscess. Interact Cardiovasc Thorac Surg. 2013;17:872-874.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
65.  Méchaï F, Aoun O, Ficko C, Barruet R, Imbert P, Rapp C. Budd-Chiari syndrome as a vascular complication of amebic liver abscess. Am J Trop Med Hyg. 2009;81:768-769.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 5]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
66.  Thati V, Nagral S. Inferior vena cava thrombus with pulmonary embolism complicating amebic liver abscess. Indian J Gastroenterol. 2014;33:299.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
67.  Trad G, Sheikhan N, Nguyen A, Valenta J, Iraninezhad H. Portal Vein Thrombosis and Pyogenic Liver Abscess With Concomitant Bacteroides Bacteremia in a Patient With COVID-19 Infection: A Case Report and Brief Review. J Investig Med High Impact Case Rep. 2022;10:23247096221084513.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 3]  [Reference Citation Analysis (0)]
68.  Etienne M, Gueit I, Abboud P, Pons JL, Jacquot S, Caron F. Fusobacterium nucleatum hepatic abscess with pylephlebitis associated with idiopathic CD4(+) T lymphocytopenia. Clin Infect Dis. 2001;32:326-328.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 33]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
69.  Linsen PVM, Schrier VJMM. Decoding pylephlebitis: Tracing the path of infected thrombosis and liver abscesses. Radiol Case Rep. 2023;18:3820-3823.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
70.  Ray S, Khanra D, Saha M, Talukdar A. Amebic Liver abscess Complicated by Inferior Vena Cava Thrombosis: A Case Report. Med J Malaysia. 2012;67:524-525.  [PubMed]  [DOI]  [Cited in This Article: ]
71.  Maffiolo C, Novellas S, Chevallier P, Brunner P, Mourou MY, Bruneton JN. Thrombophlebitis of the hepatic veins: complication of a Klebsiella liver abscess. Clin Imaging. 2006;30:63-65.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 11]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
72.  Gupta A, Dhua AK, Siddiqui MA, Dympep B, Grover V, Gupta VK, Sen A. Inferior vena cava thrombosis in a pediatric patient of amebic liver abscess. J Indian Assoc Pediatr Surg. 2013;18:33-35.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 5]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
73.  Khan S, Ameen Rauf M. Amoebic liver abscesses complicated by inferior vena cava and right atrium thrombus. Trop Doct. 2009;39:177-180.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 9]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
74.  Lee JY, Lee HN, Lee WH, Shin HC, Kim SS, Hwang JA. Liver Abscess Caused by Klebsiella oxytoca with Hepatic Artery Pseudoaneurysm: A Case Report. Taehan Yongsang Uihakhoe Chi. 2020;81:1448-1452.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
75.  Tacconi D, Lapini L, Giorni P, Corradini S, Caremani M. Pseudoaneurysm of the hepatic artery, a rare complication of an amebic liver abscess. J Ultrasound. 2009;12:49-52.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3]  [Cited by in F6Publishing: 5]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
76.  Ferraioli G, Garlaschelli A, Zanaboni D, Gulizia R, Brunetti E, Tinozzi FP, Cammà C, Filice C. Percutaneous and surgical treatment of pyogenic liver abscesses: observation over a 21-year period in 148 patients. Dig Liver Dis. 2008;40:690-696.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 44]  [Cited by in F6Publishing: 43]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
77.  Liu CH, Gervais DA, Hahn PF, Arellano RS, Uppot RN, Mueller PR. Percutaneous hepatic abscess drainage: do multiple abscesses or multiloculated abscesses preclude drainage or affect outcome? J Vasc Interv Radiol. 2009;20:1059-1065.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 55]  [Cited by in F6Publishing: 54]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
78.  Zerem E, Hadzic A. Sonographically guided percutaneous catheter drainage versus needle aspiration in the management of pyogenic liver abscess. AJR Am J Roentgenol. 2007;189:W138-W142.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 106]  [Cited by in F6Publishing: 77]  [Article Influence: 4.5]  [Reference Citation Analysis (0)]
79.  Ghosh S, Sharma S, Gadpayle AK, Gupta HK, Mahajan RK, Sahoo R, Kumar N. Clinical, laboratory, and management profile in patients of liver abscess from northern India. J Trop Med. 2014;2014:142382.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 36]  [Cited by in F6Publishing: 33]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
80.  Fiore M, Cascella M, Bimonte S, Maraolo AE, Gentile I, Schiavone V, Pace MC. Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies. Infect Drug Resist. 2018;11:177-186.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 13]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
81.  Paccoud O, Fontaine H, Bougnoux ME, Lortholary O, Suarez F, Lanternier F. Portal vein thrombosis as a long-term complication of chronic hepatosplenic candidiasis in an allogeneic haematopoietic stem-cell transplant recipient. Clin Microbiol Infect. 2020;26:967-968.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 2]  [Cited by in F6Publishing: 2]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
82.  Reed DH, Nash AF, Valabhji P. Radiological diagnosis and management of a solitary tuberculous hepatic abscess. Br J Radiol. 1990;63:902-904.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 47]  [Article Influence: 1.4]  [Reference Citation Analysis (0)]
83.  Essop AR, Segal I, Posen J, Noormohamed N. Tuberculous abscess of the liver. A case report. S Afr Med J. 1983;63:825-826.  [PubMed]  [DOI]  [Cited in This Article: ]
84.  Venkatesh SK, Tan LK, Siew EP, Putti TC. Macronodular hepatic tuberculosis associated with portal vein thrombosis and portal hypertension. Australas Radiol. 2005;49:322-324.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 14]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
85.  Zheng SM, Lin N, Tang SH, Yang JY, Wang HQ, Luo SL, Zhang Y, Mu D. Isolated hepatic tuberculosis associated with portal vein thrombosis and hepatitis B virus coinfection: A case report and review of the literature. World J Clin Cases. 2021;9:9310-9319.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in CrossRef: 1]  [Cited by in F6Publishing: 1]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
86.  Magacha HM, Vedantam V, Vedantam N, Jagadish A. Liver Hydatid Cyst Masquerading as a Liver Abscess. Cureus. 2023;15:e34334.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]
87.  Ergüney S, Tortum O, Taspinar AH, Ertem M, Gazioğlu E. [Complicated hydatid cysts of the liver]. Ann Chir. 1991;45:584-589.  [PubMed]  [DOI]  [Cited in This Article: ]
88.  Kirmizi S, Kayaalp C, Yilmaz S. Hydatid liver cyst causing portal vein thrombosis and cavernous transformation: a case report and literature review. Gastroenterol Hepatol Bed Bench. 2016;9:331-335.  [PubMed]  [DOI]  [Cited in This Article: ]
89.  Moradi A, Ehsani Z, Nadjafi-Semnani A, Yazdi NA. Liver hydatidosis disease with portal vein invasion: Report of a rare case and review of literature. Radiol Case Rep. 2024;19:445-448.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
90.  Sarawagi R, Keshava SN, Surendrababu NR, Zachariah UG, Eapen EC. Budd-Chiari syndrome complicating hydatid cyst of the liver managed by venoplasty and stenting. Cardiovasc Intervent Radiol. 2011;34 Suppl 2:S202-S205.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 7]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
91.  Rajesh R, Gupta M, Kaur N, Lehl SS, Tahlan A, Kaur D. Prevalence of vascular thrombosis in patients with liver abscess. Trop Doct. 2024;54:23-26.  [PubMed]  [DOI]  [Cited in This Article: ]  [Reference Citation Analysis (0)]